Development and validation of a self-efficacy scale for use in British patients with rheumatoid arthritis (RASE)

Abstract

Careful construction means that the RASE examines beliefs in potential ability to perform tasks, rather than actual ability, performance or outcome expectancy. It shows good face validity and reliability, plus reasonable construct validity and sensitivity. Further studies are needed to support the validation of this new scale.

The Impact Triad (Severity, Importance, Self-management) as a Method of Enhancing Measurement of Personal Life Impact of Rheumatic Diseases

“…An alternative is to use a self-management instrument that assesses beliefs about the overall ability to manage a health condition. An example is the 28-item RA Self Efficacy (RASE) questionnaire, which measures beliefs in the ability to use specific types of self-management for specific purposes 18 . Although the RASE gives a global score, we recognize that beliefs about self-management, like self-efficacy, might be item-specific.…”

Application of the general perceived self-efficacy scale in cardiovascular rehabilitation

“…In chronic diseases such as diabetes, cancer, arthritis, COPD and others causing impaired mobility or pain, as well as in chronic diseases in the elderly, self-efficacy has mainly been studied as a predictor of adherence to treatment and of treatments capable of increasing the self-management of disease and daily coping tasks [10][11][12][13][14][15][16][17][18][19]. Bandura underlines the mediating role of self-efficacy in the relationship between biomedical factors and the quality of life of patients with chronic diseases: "functional limitations may be governed more by beliefs of capability than by the degree of actual physical impairment" [9, p. 300].…”

Self‐efficacy in rheumatoid arthritis: translation and test of validity, reliability and sensitivity of the Danish version of the Rheumatoid Arthritis Self‐Efficacy Questionnaire (RASE)

“…Hewlett et al developed the Rheumatoid Arthritis Self-Effi cacy Questionnaire (RASE) (Hewlett et al, 2001) in 2001 for measuring self-effi cacy among British persons with RA as an alternative to the Arthritis SelfEffi cacy Scale (ASES) (Lorig et al, 1989). RASE was developed for RA patients only, whereas ASES was developed for various types of arthritis, including RA as a minor subgroup (Lorig et al, 1989).…”

“…RASE was developed for RA patients only, whereas ASES was developed for various types of arthritis, including RA as a minor subgroup (Lorig et al, 1989). RASE was developed with input from patients and health professionals, and showed good face validity and reliability, and reasonable construct validity and sensitivity (Hewlett et al, 2001). The sensitivity was further tested in 128 persons participating in educational programmes of varying length (Hewlett et al, 2008).…”

“…ASES has been translated into several languages (Barlow et al, 1997;Gonzalez et al, 1995;Krabbe et al, 2003;Lomi et al, 1992). ASES has been criticized for being diffi cult to complete and may measure actual ability or outcome expectancy rather than self-effi cacy (Brady, 1997;Hewlett et al, 2001;Lorig et al, 1989). RASE has not been translated and tested in other languages or cultures.…”